Analysis of potential adulteration in herbal medicines and dietary supplements for the weight control by capillary electrophoresis

Four different phytopharmaceutical dosage forms for use in weight control programs were analyzed. Two different ground herbal blends and their correspondent infusions, a capsule and a tincture were investigated for the presence of compounds used as adulterants in these products. A capillary electrop...

Descripción completa

Detalles Bibliográficos
Autores: Cianchino, Valeria Andrea, Acosta, Maria Gimena, Ortega, Claudia Alicia, Martinez, Luis Dante, Gomez, Maria Roxana Anabel
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2008
País:Argentina
Institución:Consejo Nacional de Investigaciones Científicas y Técnicas
Repositorio:CONICET Digital (CONICET)
Idioma:inglés
OAI Identifier:oai:ri.conicet.gov.ar:11336/92823
Acceso en línea:http://hdl.handle.net/11336/92823
Access Level:acceso abierto
Palabra clave:ADULTERANTS
CAPILLARY ELECTROPHORESIS
DIETARY SUPPLEMENTS
QUALITY CONTROL
WEIGHT CONTROL DRUGS
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
Descripción
Sumario:Four different phytopharmaceutical dosage forms for use in weight control programs were analyzed. Two different ground herbal blends and their correspondent infusions, a capsule and a tincture were investigated for the presence of compounds used as adulterants in these products. A capillary electrophoresis (CE) method was developed and validated. The optimized experimental conditions were: BGE, sodium tetraborate buffer 20 mM, pH 9.2, voltage applied 30 kV, capillary temperature 25 °C, injection sample at 0.5 Psi during 5 s. Ephedrine, norephedrine, caffeine and furosemide were baseline separated in less than 7 min; the migration times were found to be 2.65, 2.90, 3.75 and 6.58 min, respectively. The analysis showed in sample 3 concentrations of 0.45 ± 0.03 mg g-1 (ephedrine), 0.33 ± 0.02 mg g-1 (norephedrine), 1.09 ± 0.41 mg g-1 (caffeine) and 0.80 ± 0.17 mg g-1 (furosemide). Caffeine content in samples 1, 2 and 4 was 0.61 ± 0.06 mg g-1, 15.66 ± 1.05 mg g-1 and 2.27 ± 0.13 mg ml-1, respectively. Linearity was obtained in the concentration range of 1-1000 μg ml-1. Limits of detection (LOD) and quantification (LOQ) were determined as 0.42 μg ml-1 and 1.40 μg ml-1 (ephedrine), 0.47 μg ml-1 and 1.40 μg ml-1 (norephedrine), 0.12 μg ml-1 and 0.48 μg ml-1 (caffeine), 0.22 μg ml-1 and 0.73 μg ml-1 (furosemide). The common constituents of the samples did not interfere with the potential adulterants. Repeatability was better than 0.24% RSD for the retention time and 1.43% for the peak area. Intermediate precision was tested by changing the capillary, the day of operation and the operator, in all the cases the %RSD was better than 3.06. © 2007 Elsevier Ltd. All rights reserved.